Navigating Europe’s Post-Approval Maze: Shortening the ‘500-Day’ Gap Between EMA Approval & Patient Access
- Decoding country-by-country HTA differences and their impact on launch timelines
- Preparing comparative data packages aligned with EU national requirements
- Strategizing launch sequencing to avoid reimbursement bottlenecks